CL2016002562A1 - Régimen de dosificación de liberación inmediata de moduladores s1p. - Google Patents
Régimen de dosificación de liberación inmediata de moduladores s1p.Info
- Publication number
- CL2016002562A1 CL2016002562A1 CL2016002562A CL2016002562A CL2016002562A1 CL 2016002562 A1 CL2016002562 A1 CL 2016002562A1 CL 2016002562 A CL2016002562 A CL 2016002562A CL 2016002562 A CL2016002562 A CL 2016002562A CL 2016002562 A1 CL2016002562 A1 CL 2016002562A1
- Authority
- CL
- Chile
- Prior art keywords
- modulators
- immediate release
- dosing regime
- regime
- dosing
- Prior art date
Links
- 239000012729 immediate-release (IR) formulation Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461977816P | 2014-04-10 | 2014-04-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2016002562A1 true CL2016002562A1 (es) | 2017-07-28 |
Family
ID=52988364
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2016002562A CL2016002562A1 (es) | 2014-04-10 | 2016-10-07 | Régimen de dosificación de liberación inmediata de moduladores s1p. |
Country Status (16)
Country | Link |
---|---|
US (3) | US20170027907A1 (es) |
EP (3) | EP4074312A1 (es) |
JP (1) | JP6674903B2 (es) |
KR (2) | KR20160141841A (es) |
CN (2) | CN106456552A (es) |
AU (2) | AU2015246036A1 (es) |
CA (1) | CA2943598C (es) |
CL (1) | CL2016002562A1 (es) |
IL (2) | IL305337A (es) |
MX (1) | MX2016013245A (es) |
PH (1) | PH12016501965A1 (es) |
RU (2) | RU2020107732A (es) |
SG (1) | SG11201607894RA (es) |
TW (1) | TW201622721A (es) |
WO (1) | WO2015155709A1 (es) |
ZA (1) | ZA201606519B (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4074312A1 (en) * | 2014-04-10 | 2022-10-19 | Novartis AG | Siponimod immediate release dosage regimen for treating autoimmune diseases |
US11629124B2 (en) | 2017-03-09 | 2023-04-18 | Novartis Ag | Solid forms comprising an oxime ether compound, compositions and methods of use thereof |
RU2020114750A (ru) * | 2017-09-29 | 2021-10-29 | Новартис Аг | Схема введения доз сипонимода |
CN111132677A (zh) * | 2017-09-29 | 2020-05-08 | 诺华股份有限公司 | 西尼莫德的给药方案 |
EP3758708A1 (en) * | 2018-03-01 | 2021-01-06 | AstraZeneca AB | Pharmaceutical compositions comprising (2s)--{(1s)-1-cyano-2-[4-(3-methyl-2-oxo-2,3-dihydro-1,3-benzoxazol-5-yl)phenyl]ethyl}-1,4-oxazepane-2-carboxamide |
CN109908095A (zh) * | 2019-04-08 | 2019-06-21 | 肇庆学院 | 一种西尼莫德片剂及制备方法 |
CA3156298A1 (en) | 2019-10-31 | 2021-05-06 | Laetitia POUZOL | Combination of a cxcr7 antagonist with an s1p1 receptor modulator |
WO2021158838A1 (en) * | 2020-02-07 | 2021-08-12 | Argentum Pharmaceuticals Llc | Dosage regimen of an s1p receptor modulator |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20170062554A (ko) * | 2008-12-18 | 2017-06-07 | 노파르티스 아게 | 1-[4-[1-(4-시클로헥실-3-트리플루오로메틸-벤질옥시이미노)-에틸]-2-에틸-벤질]-아제티딘-3-카르복실산의 헤미푸마레이트 염 |
PL2379069T3 (pl) * | 2008-12-22 | 2015-08-31 | Novartis Ag | Schemat dawkowania agonisty receptora S1P |
SI3409274T1 (sl) * | 2008-12-22 | 2020-03-31 | Novartis Ag | Režim odmerjanja za S1P receptor agonist |
CA3129729A1 (en) * | 2009-09-29 | 2011-04-07 | Novartis Ag | Dosage regimen of an s1p receptor modulator |
PT2661261T (pt) * | 2011-01-07 | 2019-10-25 | Novartis Ag | Formulações imunossupressoras. |
WO2012095853A1 (en) | 2011-01-10 | 2012-07-19 | Novartis Pharma Ag | Modified release formulations comprising sip receptor modulators |
JP2014530835A (ja) * | 2011-10-21 | 2014-11-20 | ノバルティスアーゲー | S1p受容体モジュレーターまたはs1p受容体アゴニストのための投薬量レジメン |
EP4074312A1 (en) * | 2014-04-10 | 2022-10-19 | Novartis AG | Siponimod immediate release dosage regimen for treating autoimmune diseases |
-
2015
- 2015-04-08 EP EP21212400.2A patent/EP4074312A1/en active Pending
- 2015-04-08 EP EP15717256.0A patent/EP3129020A1/en not_active Withdrawn
- 2015-04-08 WO PCT/IB2015/052550 patent/WO2015155709A1/en active Application Filing
- 2015-04-08 MX MX2016013245A patent/MX2016013245A/es unknown
- 2015-04-08 AU AU2015246036A patent/AU2015246036A1/en not_active Abandoned
- 2015-04-08 US US15/300,989 patent/US20170027907A1/en not_active Abandoned
- 2015-04-08 IL IL305337A patent/IL305337A/en unknown
- 2015-04-08 SG SG11201607894RA patent/SG11201607894RA/en unknown
- 2015-04-08 EP EP20215763.2A patent/EP3831378A1/en not_active Withdrawn
- 2015-04-08 KR KR1020167031062A patent/KR20160141841A/ko active Application Filing
- 2015-04-08 RU RU2020107732A patent/RU2020107732A/ru unknown
- 2015-04-08 CN CN201580031360.0A patent/CN106456552A/zh active Pending
- 2015-04-08 CA CA2943598A patent/CA2943598C/en active Active
- 2015-04-08 RU RU2016143979A patent/RU2715734C2/ru not_active Application Discontinuation
- 2015-04-08 KR KR1020227039781A patent/KR20220156981A/ko not_active Application Discontinuation
- 2015-04-08 CN CN202310667400.7A patent/CN116650467A/zh active Pending
- 2015-04-08 TW TW104111330A patent/TW201622721A/zh unknown
- 2015-04-08 JP JP2016561731A patent/JP6674903B2/ja active Active
-
2016
- 2016-09-21 ZA ZA2016/06519A patent/ZA201606519B/en unknown
- 2016-09-22 IL IL247986A patent/IL247986A0/en unknown
- 2016-10-04 PH PH12016501965A patent/PH12016501965A1/en unknown
- 2016-10-07 CL CL2016002562A patent/CL2016002562A1/es unknown
-
2018
- 2018-08-21 US US16/106,072 patent/US20190054065A1/en not_active Abandoned
-
2020
- 2020-05-12 AU AU2020203107A patent/AU2020203107B2/en active Active
- 2020-06-02 US US16/890,722 patent/US20220016076A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
TW201622721A (zh) | 2016-07-01 |
SG11201607894RA (en) | 2016-10-28 |
JP2017510607A (ja) | 2017-04-13 |
CA2943598C (en) | 2023-03-07 |
PH12016501965A1 (en) | 2017-01-09 |
EP4074312A1 (en) | 2022-10-19 |
CA2943598A1 (en) | 2015-10-15 |
EP3831378A1 (en) | 2021-06-09 |
JP6674903B2 (ja) | 2020-04-01 |
RU2715734C2 (ru) | 2020-03-03 |
US20170027907A1 (en) | 2017-02-02 |
ZA201606519B (en) | 2017-11-29 |
CN116650467A (zh) | 2023-08-29 |
EP3129020A1 (en) | 2017-02-15 |
KR20220156981A (ko) | 2022-11-28 |
RU2020107732A (ru) | 2020-03-30 |
IL247986A0 (en) | 2016-11-30 |
US20220016076A1 (en) | 2022-01-20 |
RU2016143979A3 (es) | 2018-11-12 |
CN106456552A (zh) | 2017-02-22 |
WO2015155709A1 (en) | 2015-10-15 |
KR20160141841A (ko) | 2016-12-09 |
US20190054065A1 (en) | 2019-02-21 |
MX2016013245A (es) | 2017-01-16 |
RU2016143979A (ru) | 2018-05-14 |
IL305337A (en) | 2023-10-01 |
AU2020203107A1 (en) | 2020-05-28 |
AU2020203107B2 (en) | 2021-10-21 |
AU2015246036A1 (en) | 2016-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA43382A (fr) | Modulateurs des récepteurs des chimiokines | |
DK3331876T3 (da) | Modulators of ror-gamma | |
MA53943A (fr) | Modulateurs de ror-gamma | |
DK3236943T3 (da) | Sammensætninger til ileo-jejunal lægemiddeladministration | |
DK3131902T3 (da) | Forbindelser som ROR-gamma-modulatorer | |
DK3229810T3 (da) | Phospholipid-ether-analoger som kræftrammende lægemiddelvehikler | |
CL2016002562A1 (es) | Régimen de dosificación de liberación inmediata de moduladores s1p. | |
BR112016026879A2 (pt) | Composição farmacêutica líquida | |
DK3125898T3 (da) | Farmakofor til trail-induktion | |
ES1137034Y (es) | Cápsula para sólidos | |
DK3145836T3 (da) | Dispenseringskapsel | |
DK3153508T3 (da) | Naphthofuranderivater til anvendelse som anticancermidler | |
DK3145488T3 (da) | Flydende farmaceutiske forbindelse | |
BR112016020077A2 (pt) | composições de lactase líquida | |
DK3230929T3 (da) | Forbedringer til tælleranordninger | |
FR3030466B3 (fr) | Valve doseuse multilame | |
MA41266A (fr) | Cataplasme | |
DK3145916T3 (da) | Imidazolderivater som formylpeptidreceptormodulatorer | |
DE112015005590A5 (de) | Dosierpumpe | |
DK2946774T3 (da) | Coatede kapsler med modificeret frigivelse | |
DK3089740T3 (da) | Farmaceutisk sammensætning | |
FR3029792B1 (fr) | Liberation maitrisee de substances actives. | |
UA29131S (uk) | Балон для лікарських засобів | |
UA29132S (uk) | Балон для лікарських засобів | |
ES1144359Y (es) | Dispositivo para suministro de medicamentos via intravenosa |